Brett Burstein

Brett Burstein, MDCM, PhD, MPH, FRCPC, FAAP, is an Associate Professor in the Department of Pediatrics at McGill University's Faculty of Medicine and Health Sciences. He holds multiple roles including Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) at the Glen site, where he is affiliated with the Child Health and Human Development Program and the Centre for Outcomes Research and Evaluation (CORE). Additionally, he practices in the Division of Emergency Medicine at the McGill University Health Centre (MUHC).

Dr. Burstein's research program focuses on improving care for febrile infants ≤90 days old, with emphasis on reducing invasive testing/hospitalization through diagnostic innovations and understanding parental decision-making preferences. His core research areas include:

• Febrile young infants and serious bacterial infections
• Viral testing methodologies and diagnostic protocols
• Sepsis management in pediatric emergency settings
• Parental preferences in shared clinical decision-making
• Healthcare standardization for infant fever management

Analysis of his 15 most recent publications reveals strong research trends in:

• COVID-19 impacts on pediatric care (testing disparities, mental health effects)
• Diagnostic optimization for febrile infants (procalcitonin alternatives, risk stratification)
• Emergency department quality improvement (trauma care metrics, workload standardization)
• Mental health interventions in emergency settings
• Healthcare equity and access studies

Dr. Burstein holds advanced degrees including MDCM (Doctor of Medicine and Master of Surgery), PhD, and Master of Public Health (MPH), with professional certifications as Fellow of the Royal College of Physicians of Canada (FRCPC) and Fellow of the American Academy of Pediatrics (FAAP).